Fergus Fleming
Chief Tech/Sci/R&D Officer at RENALYTIX PLC
Net worth: 240 999 $ as of 2024-03-30
Profile
Fergus Fleming is currently the Director & Chief Technology Officer at Renalytix Plc since 2018 and the Managing Director at Ff Consulting Ltd.
since 2013.
He previously worked as the Head-Business Development at Oncomark Ltd.
from 2016 to 2018.
Mr. Fleming completed his undergraduate degree from the National University of Ireland Galway.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
RENALYTIX PLC
0.57% | 2024-04-09 | 569,481 ( 0.57% ) | 240 999 $ | 2024-03-30 |
Fergus Fleming active positions
| Companies | Position | Start |
|---|---|---|
| RENALYTIX PLC | Chief Tech/Sci/R&D Officer | 2018-03-14 |
| Ff Consulting Ltd. | Chief Executive Officer | 2013-05-31 |
Former positions of Fergus Fleming
| Companies | Position | End |
|---|---|---|
Oncomark Ltd.
 Oncomark Ltd. Medical SpecialtiesHealth Technology Oncomark Ltd. Engages in the development and application of biomarker panels. The firm’s products include OncoMasTR and pipeline assays. The company was founded by William M. Gallagher and Steve Carl Penney in 2007 and is headquartered in Belfield, Ireland. | Corporate Officer/Principal | 2018-09-30 |
Training of Fergus Fleming
| National University of Ireland Galway | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| RENALYTIX PLC | Technology Services |
| Private companies | 2 |
|---|---|
Oncomark Ltd.
Oncomark Ltd. Medical SpecialtiesHealth Technology Oncomark Ltd. Engages in the development and application of biomarker panels. The firm’s products include OncoMasTR and pipeline assays. The company was founded by William M. Gallagher and Steve Carl Penney in 2007 and is headquartered in Belfield, Ireland. | Health Technology |
| Ff Consulting Ltd. |
- Stock Market
- Insiders
- Fergus Fleming
